Pro Medicus (OTCMKTS:PMCUF) Trading Down 12.9% – What’s Next?

Pro Medicus Limited (OTCMKTS:PMCUF) traded down 12.9% during mid-day trading on Thursday . The company traded as low as $114.00 and last traded at $114.00. 186 shares were traded during trading, a decline of 72% from the average daily volume of 664 shares. The stock had previously closed at $130.92.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group lowered Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Pro Medicus has a consensus rating of “Hold” and a consensus price target of $155.00.

Pro Medicus Stock Performance

The firm has a market capitalization of $11.91 billion and a P/E ratio of 9,666.67. The firm has a 50 day moving average price of $117.05 and a two-hundred day moving average price of $107.43.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.